{"id":"W4410598109","doi":"10.1093/cid/ciaf235","title":"2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Vilobelimab","year":2025,"lang":"en","type":"article","venue":"Clinical Infectious Diseases","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Impact","funders":"National Cancer Institute; National Institutes of Health; Infectious Diseases Society of America","keywords":"Guideline; Medicine; Grading (engineering); Coronavirus disease 2019 (COVID-19); Clinical Practice; 2019-20 coronavirus outbreak; Intensive care medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); MEDLINE; Family medicine; Infectious disease (medical specialty); Pathology; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01206891,0.001605023,0.004041218,0.006766735,0.001307692,0.003800353,0.003866978,0.009123744,0.0113416],"category_scores_gemma":[0.05820908,0.001206495,0.006234762,0.005731013,0.001008913,0.002644974,0.00227012,0.009164875,0.01007562],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005493094,"about_ca_system_score_gemma":0.02280941,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02600205,"about_ca_topic_score_gemma":0.05615098,"domain_scores_codex":[0.9823563,0.00634421,0.005147323,0.0006237174,0.004948074,0.0005805208],"domain_scores_gemma":[0.9545053,0.01200168,0.006788936,0.000715161,0.02418522,0.001803664],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008242547,0.0000891384,0.0005407819,0.01292676,0.0003781248,0.000225931,0.00017386,0.0002449076,0.000333901,0.00150319,0.8196105,0.1638905],"study_design_scores_gemma":[0.0005713184,0.0001211363,0.002455838,0.07371838,0.001379452,0.0006196554,0.0001330926,0.0003748274,0.0002443835,0.003028007,0.9172717,0.0000821696],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.001877442,0.4079301,0.01633736,0.4204099,0.03794054,0.01023078,0.01989275,0.001003567,0.08437746],"genre_scores_gemma":[0.01011713,0.559194,0.130661,0.2052804,0.02166093,0.01400365,0.03343545,0.0005046871,0.02514273],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.02600205,"threshold_uncertainty_score":0.06382728,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05867739368596873,"score_gpt":0.501228392975757,"score_spread":0.4425509992897883,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}